Matti Eskelinen

Eskelinen, Maaret; Meklin, Jannica; Selander, Tuomas; Syrjänen, Kari; Eskelinen, Matti. 2021. A Diagnostic Score (DS) in the Difficult Diagnosis of Non-specific Abdominal Pain (NSAP) In vivo 35 5: 2729-2738. 2021

Eskelinen, Maaret; Meklin, Jannica; Syrjänen, Kari; Eskelinen, Matti. 2021. A Diagnostic Score (DS) Is a Powerful Tool in Diagnosis of Acute Appendicitis in Elderly Patients With Acute Abdominal Pain Anticancer research 41 3: 1459-1469. 2021

Eskelinen, Maaret; Meklin, Jannica; Syrjänen, Kari; Eskelinen, Matti. 2021. A Diagnostic Score for Acute Small Bowel Obstruction Anticancer research 41 4: 1959-1970. 2021

Eskelinen, Maaret; Meklin, Jannica; Syrjänen, Kari; Eskelinen, Matti. 2021. A Diagnostic Score for Reliable Confirmation of Acute Renal Colic Among Patients With Acute Abdominal Pain Anticancer research 41 6: 3045-3054. 2021

Eskelinen, Maaret; Meklin, Jannica; Syrjänen, Kari; Eskelinen, Matti. 2021. Pediatric Acute Appendicitis Score in Children With Acute Abdominal Pain (AAP) Anticancer research 41 1: 297-306. 2021

Meklin, Jannica; Eskelinen, Maaret; Guimaraes, Denise Peixoto; Selander, Tuomas; Inkinen, Jenni; Tiusanen, Tapani; Syrjänen, Kari; Eskelinen, Matti. 2021. The New Generation Immunochemical Test for Fecal Occult Blood (ColonView Quick Test) Shows a High Diagnostic Accuracy in Colorectal Cancer Detection Anticancer research 41 10: 5071-5079. 2021

Meklin, Jannica; Eskelinen, Maaret; Guimaraes, Denise Peixoto; Selander, Tuomas; Tiusanen, Tapani; Syrjanen, Kari; Eskelinen, Matti. 2021. The Automatically Analyzed (AA) ColonView (CV) Quick Test for Fecal Occult Blood Shows Higher Diagnostic Accuracy in Detection of Colorectal Adenoma than Visually Analyzed Tests Anticancer research 41 11: 5517-5525. 2021

Saimanen, Iina; Kuosmanen, Viivi; Harju, Jukka; Selander, Tuomas; Aspinen, Samuli; Eskelinen, Matti. 2021. A Finnish Version of RAND-36-Item Health Survey Versus Structured Interview 8 Years Postoperatively In vivo 35 2: 907-911. 2021

Eskelinen, Maaret; Meklin, Jannica; Selander, Tuomas; Syrjänen, Kari; Eskelinen, Matti. 2021. History-taking, Clinical Signs, Tests and Scores for Detection of Non-organic Dyspepsia (NOD) Among Patients With Acute Abdominal Pain (AAP) Cancer Diagnosis & Prognosis 1 4: 264-274. 2021

Meklin, Jannica; Syrjänen, Kari; Eskelinen; Matti. 2020. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests Anticancer research 40 7: 3591-3604. 2020

Ruottinen, Maiju; Kaaronen, Viivi; Saimanen, Iina; Kuosmanen, Viivi; Kärkkäinen, Jari; Selander, Tuomas; Aspinen, Samuli; Eskelinen, Matti. 2020. The Induction of Antioxidant Catalase Enzyme With Decrease of Plasma Malonidialdehyde: An Important Reactive Oxidative Species Inhibiting Mechanism Anticancer research 40 10: 5701-5706. 2020

Ruottinen, M; Kuosmanen, V; Saimanen, I; Kaaronen, V; Rahkola, D; Holopainen, A; Selander, T; Kokki, H; Kokki, M; Eskelinen, M. 2020. The Rectus Sheath Block (RSB) Analgesia Following Laparotomy Could Affect Malonidialdehyde (MDA) Concentrations in Benign Disease and Cancer Anticancer research 40 1: 253-259. 2020

Meklin, Jannica; Eskelinen, Maaret; Syrjänen, Kari; Eskelinen, Matti. 2020. Gender-specific Performance of a Diagnostic Score in Acute Appendicitis In vivo 34 6: 3687-3703. 2020

Meklin, Jannica; Syrjänen, Kari; Eskelinen, Matti. 2020. Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests Anticancer research 40 2: 575-581. 2020

Meklin, Jannica; Eskelinen, Maaret; Syrjanen, Kari; Eskelinen, Matti. 2020. Leucocyte Count Does Not Improve the Diagnostic Performance of a Diagnostic Score (DS) in Distinguishing Acute Appendicitis (AA) from Nonspecific Abdominal Pain (NSAP) In vivo 34 6: 3327-3339. 2020

Lammi, J P; Eskelinen, M; Tuimala, J; Selander, T; Saarnio, J; Rantanen, T. 2020. Perioperative Changes in Hemoglobin Levels During Major Hepatopancreatic Surgery in Transfused and Non-Transfused Patients Scandinavian journal of surgery 2021; 110 3: 407-413. 2020

Eskelinen, Maaret; Meklin, Jannica; Syrjänen, Kari; Eskelinen, Matti. 2020. Performance of a Diagnostic Score in Confirming Acute Cholecystitis Among Patients With Acute Abdominal Pain Anticancer research 40 12: 6947-6956. 2020

Kuosmanen, V; Ruottinen, M; Rahkola, D; Saimanen, I; Kaaronen, V; Selander, T; Purdy, M; Kokki, H; Kokki, M; Eskelinen, M. 2019. Brief Pain Inventory (BPI) Health Survey After Midline Laparotomy With the Rectus Sheath Block (RSB) Analgesia: A Randomised Trial of Patients With Cancer and Benign Disease Anticancer research 39 12: 6751-6757. 2019

Kuosmanen, V; Saimanen, I; Rahkola, D; Kärkkäinen, J; Selander, T; Purdy, M; Kokki, H; Kokki, M; Eskelinen, M. 2019. Rectus Sheath Block (RSB) Analgesia Could Enhance Significantly the Patient Satisfaction Following Midline Laparotomy in Benign Disease and in Cancer: A Prospective Study With Special Reference to Nitrosative Stress Marker Nitrotyrosine (NT) Plasma Concentrations Anticancer research 39 3: 1383-1389. 2019

Saimanen, I; Kuosmanen, V; Rahkola, D; Selander, T; Kärkkäinen, J; Harju, J; Aspinen, S; Eskelinen, M. 2019. RAND-36-Item Health Survey: A Comprehensive Test for Long-term Outcome and Health Status Following Surgery Anticancer research 39 6: 2927-2933. 2019

Saimanen, I; Rahkola, D; Kuosmanen, V; Kärkkäinen, J; Selander, T; Holopainen, A; Aspinen, S; Eskelinen, M. 2019. Nitrotyrosine (NT), a Nitrosative Stress Biomarker, Plasma Concentrations in Gallstone Disease and Cancer Patients Anticancer research 39 2: 809-814. 2019

Syrjänen, Kari; Eskelinen, Matti; Peetsalu, Ants; Sillakivi, Toomas; Sipponen, Pentti; Härkönen, Matti; Paloheimo, Lea; Mäki, Minna; Tiusanen, Tapani; Suovaniemi, Osmo; DiMario, Francesco; Fan, Zhu Ping. 2019. GastroPanel® Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review Anticancer research 39 3: 1091-1104. 2019

Saimanen, Iina; Kuosmanen, Viivi; Kärkkäinen, Jari; Selander, Tuomas; Aspinen, Samuli; Holopainen, Anu; Rantanen, Tuomo; Eskelinen, Matti. 2018. Cholecystectomy Patients with High Plasma Level of Catalase Have Significantly Lower Analgesia Requirement: A Prospective Study of Two Different Cholecystectomy Techniques with Special Reference to Patients with Cancer ANTICANCER RESEARCH 38 9: 5417-5422. 2018

Saimanen, Iina; Kärkkäinen, Jari; Selander, Tuomas; Purdy, Martin; Kokki, Merja; Kokki, Hannu; Eskelinen Matti. 2018. Plasma Catalase in Relation to Pain Following Midline Laparotomy: A Prospective Study of Patients with Benign Diseases and Patients with Cancer ANTICANCER RESEARCH 38 11: 6479-6484. 2018

Purdy, Martin; Kinnunen, Mari; Kokki, Merja; Anttila, Maarit; Eskelinen, Matti; Hautajärvi, Heidi; Lehtonen, Marko; Kokki, Hannu. 2018. A prospective, randomized, open label, controlled study investigating the efficiency and safety of 3 different methods of rectus sheath block analgesia following midline laparotomy Medicine 97 7: e9968. 2018

Lammi, JP; Eskelinen, M; Tuimala, J; Saarnio, J; Rantanen, T. 2018. Blood Transfusions in Major Pancreatic Surgery: A 10-Year Cohort Study Including 1404 Patients Undergoing Pancreatic Resections in Finland Scandinavian journal of surgery 2019; 108 3: 1-6. 2018

Kärkkäinen, Jari; Selander, Tuomas; Purdy, Martin; Juvonen, Petri; Eskelinen, Matti. 2018. Patients with Increased Levels of the Oxidative Stress Biomarker SOD1 Appear to Have Diminished Postoperative Pain After Midline Laparotomy: A Randomised Trial with Special Reference to Postoperative Pain Score (NRS) ANTICANCER RESEARCH 38 2: 1003-1008. 2018

Kärkkäinen, Jari; Saimanen, Iina; Selander, Tuomas; Aspinen, Samuli; Harju, Jukka; Juvonen, Petri; Eskelinen, Matti. 2018. Gallstone Patients with Enhanced Oxidative Stress Biomarker Superoxide Dismutase (SOD1) Plasma Levels Have Significantly Lower Number of Postoperative Analgesic Oxycodone Doses: A Prospective Study with Special Reference to Cancer Patients ANTICANCER RESEARCH 38 6: 3573-3578. 2018

Karihtala, P; Porvari, K; Soini, Y; Eskelinen, M; Juvonen, P; Haapasaari, KM. 2018. Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiation and Relapse-Free Survival Oncology 2019; 96 3: 164-170. 2018

Eskelinen Matti, Selander Tuomas, Ollonen Paula, Korhonen Riika. 2017. Moderate/severe depression (MADRS) can affect the quality of life and outcome among patients admitted to breast cancer diagnosis unit. ANTICANCER RESEARCH 37 5: 2641-2647. 2017

Eskelinen, Matti; Korhonen, Riika; Selander, Tuomas; Ollonen, Paula. 2017. Beck Depression Inventory as a Predictor of Long-term Outcome Among Patients Admitted to the Breast Cancer Diagnosis Unit: A 25-year Cohort Study in Finland ANTICANCER RESEARCH 37 2: 819-824. 2017

Kärkkäinen Jari, Aspinen Samuli, Harju Jukka, Juvonen Petri, Pulkki Kari, Eskelinen Matti. 2017. Plasma Glutathione Peroxidase (GPX1) Levels and Oxidative Stress in Gallstone Patients Operated with Two Different Cholecystectomy Techniques: A Randomized Study with Special Reference to Cancer Patients. ANTICANCER RESEARCH 37 12: 6921-6927. 2017

Purdy M, Kärkkäinen J, Kokki M, Anttila M, Aspinen S, Juvonen P, Kokki H, Pulkki K, Rantanen T, Eskelinen M. 2017. Does rectus sheath block analgesia alter levels of the oxidative stress biomarker glutathione peroxidase: A randomised trial of patients with cancer and benign disease. ANTICANCER RESEARCH 37 2: 897-902. 2017

Purdy Martin, Kokki Merja, Anttila Maarit, Aspinen Samuli, Juvonen Petri, Korhonen Riika, Selander Tuomas, Kokki Hannu, Eskelinen Matti. 2016. Does the Rectus Sheath Block Analgesia Reduce the Inflammatory Response Biomarkers' IL-1ra, IL-6, IL-8, IL-10 and IL-1ß Concentrations Following Surgery? : A Randomized Clinical Trial of Patients with Cancer and Benign Disease. ANTICANCER RESEARCH 36 6: 3005-3011. 2016

Regalado G, Lintula H, Kokki H, Kröger H, Väätäinen U, Eskelinen M. 2016. Six-year outcome after non-surgical versus surgical treatment of acute primary patellar dislocation in adolescents: a prospective randomized trial. KNEE SURGERY, SPORTS TRAUMATOLOGY, ARTHROSCOPY 2016; 24 1: 6-11. 2016

Purdy Martin, Kokki Merja, Anttila Maarit, Aspinen Samuli, Juvonen Petri, Selander Tuomas, Kokki Hannu, Pulkki Kari, Eskelinen Matti. 2016. Does Post-Surgery Placement of Rectus Sheath Block Analgesia Alter the Oxidative Stress Biomarker 8-OHdG Concentrations: A Randomised Trial of Patients with Cancer and Benign Disease. Cancer Genomics and Proteomics 13 3: 239-244. 2016

Käkelä P, Männistö V, Ilves I, Vaittinen M, Tauriainen MM, Eskelinen M, Gylling H, Paajanen H, Pihlajamäki J. 2016. Serum plant sterols associate with Gallstone disease independent of weight loss and non-alcoholic fatty liver disease. OBESITY SURGERY 27 5: 1284-1291. 2016

Aspinen Samuli, Kinnunen Mari, Harju Jukka, Juvonen Petri, Selander Tuomas, Holopainen Anu, Kokki Hannu, Pulkki Kari, Eskelinen Matti. 2016. Inflammatory response to surgical trauma in patients with minilaparotomy cholecystectomy versus laparoscopic cholecystectomy: a randomised multicentre study. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51 6: 739-744. 2016

Aspinen Samuli, Harju Jukka, Juvonen Petri, Selander Tuomas, Kokki Hannu, Pulkki Kari, Eskelinen Matti Johannes. 2016. The plasma 8-OHdG levels and oxidative stress following cholecystectomy: a randomised multicentre study of patients with minilaparotomy cholecystectomy versus laparoscopic cholecystectomy. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51 12: 1507-1511. 2016

Aspinen S, Kärkkäinen J, Harju J, Juvonen P, Kokki H, Eskelinen M. 2016. Improvement in the quality of life following cholecystectomy: a randomized multicenter study of health status (RAND-36) in patients with laparoscopic cholecystectomy versus minilaparotomy cholecystectomy. QUALITY OF LIFE RESEARCH 2017; 26 3: 665-671. 2016

Aspinen Samuli, Harju Jukka, Kinnunen Mari, Juvonen Petri, Kokki Hannu, Eskelinen Matti. 2015. A randomized multicenter study of minilaparotomy cholecystectomy versus laparoscopic cholecystectomy with ultrasonic dissection in both groups SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51; 2016 3: 354-9. 2015

Eskelinen Matti, Korhonen Riika, Selander Tuomas, Ollonen Paula. 2015. Agreement between hopelessness/helplessness and Montgomery-Asberg depression rating scale in healthy individuals and in patients with benign breast disease and breast cancer a prospective case-control study in Finland. ANTICANCER RESEARCH 35 4: 2215-2221. 2015

Eskelinen Matti, Korhonen Riika, Selander Tuomas, Ollonen Paula. 2015. Emotional Personality/Proximity Versus Emotional Authenticity in Patient-Physician Communication in Healthy Study Participants, and in Patients with Benign Breast Disease, and Breast Cancer: A Prospective Case-Control Study in Finland. ANTICANCER RESEARCH 35 3: 1627-1633. 2015

Eskelinen Matti, Korhonen Riika, Selander Tuomas, Ollonen Paula. 2015. Suicidal Ideation Versus Hopelessness/Helplessness in Healthy Individuals and in Patients with Benign Breast Disease and Breast Cancer: A Prospective Case-control Study in Finland. ANTICANCER RESEARCH 35 6: 3543-3551. 2015

Eskelinen Matti, Korhonen Riika, Selander Tuomas, Ollonen Paula. 2015. The Relation of Hopelessness/Helplessness versus Beck Depression Inventory (BDI) in Healthy Individuals and in Patients with Benign Breast Disease and Breast Cancer: A Prospective Case-control Study in Finland. ANTICANCER RESEARCH 35 2: 941-947. 2015

Piirainen Annika, Kokki Hannu, Immonen Satu, Eskelinen Matti, Häkkinen Merja R, Hautajärvi Heidi, Kokki Merja. 2015. A Dose-Finding Study of Dexketoprofen in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial on Effects on the Analgesic Concentration of Oxycodone. DRUGS IN R&D 15 4: 319-328. 2015

Vaittinen Maija, Kolehmainen Marjukka, Rydén Mikael, Eskelinen Matti, Wabitsch Martin, Pihlajamäki Jussi, Uusitupa Matti, Pulkkinen Leena. 2015. MFAP5 is Related to Obesity-Associated Adipose Tissue and Extracellular Matrix Remodeling and Inflammation. OBESITY (SILVER SPRING, MD.) 23 7: 1371-1378. 2015

Kiuru E, Kokki H, Juvonen P, Lintula H, Paajanen H, Gissler M, Eskelinen M. 2014. The Impact of Age and Sex Adjusted Body Mass Index (ISO-BMI) in Obese Versus Non-obese Children and Adolescents with Cholecystectomy. IN VIVO (ATHENS) 28 4: 615-619. 2014

Soini Y, Eskelinen M, Juvonen P, Kärjä V, Haapasaari KM, Saarela A, Karihtala P. 2014. Strong claudin 5 expression is a poor prognostic sign in pancreatic adenocarcinoma. Tumor Biology 35 4: 3803-3808. 2014

Soini Y, Eskelinen M, Juvonen P, Kärjä V, Haapasaari KM, Saarela A, Karihtala P. 2014. Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma. PATHOLOGY RESEARCH AND PRACTICE 210 1: 35-39. 2014

Pulkkinen J, Eskelinen M, Kiviniemi V, Kotilainen T, Pöyhönen M, Kilpeläinen L, Käkelä P, Kastarinen H, Paajanen H. 2014. Effect of statin use on outcome of symptomatic cholelithiasis: a case-control study. BMC Gastroenterology 14 119: 1-7. 2014

Paajanen Hannu, Suuronen Satu, Eskelinen Matti, Hytönen Santtu, Juvonen Petri. 2014. Frequency of bile leak after laparoscopic cholecystectomy: audit of a surgical residency program. AMERICAN SURGEON 80 1: 91-94. 2014

Juvonen Petri, Lehtimäki Tiina, Eskelinen Matti, Ilves Imre, Vanninen Ritva, Miettinen Pekka, Paajanen Hannu. 2014. The Need for Surgery in Acute Abdominal Pain: A Randomized Study of Abdominal Computed Tomography. IN VIVO (ATHENS) 28 3: 305-309. 2014

Aspinen S, Harju J, Juvonen P, Karjalainen K, Kokki H, Paajanen H, Eskelinen M. 2014. A Prospective, Randomized Study Comparing Minilaparotomy and Laparoscopic Cholecystectomy as a Day-Surgery Procedure: 5-Year Outcome. SURGICAL ENDOSCOPY 28 3: 827-32. 2014

Eskelinen M, Ollonen P. 2014. Contribution of emotional distance and reserve in patient-physician communication in healthy study patients, and in patients with benign breast disease and breast cancer: a prospective case-control study in Finland. ANTICANCER RESEARCH 34 3: 1269-1274. 2014

Eskelinen M, Korhonen R, Selander T, Ollonen P. 2014. The Self-Rating Score (SRS) Versus the Examiner Rating Score (ERS) in Measuring Helplessness in Healthy Individuals and in Patients with Benign Breast Disease and Breast Cancer: A Prospective Case-Control Study in Finland. ANTICANCER RESEARCH 34 10: 5677-5682. 2014

Aspinen Samuli, Harju Jukka, Juvonen Petri, Kokki Hannu, Remes Veikko, Scheinin Tom, Eskelinen Matti. 2014. A prospective, randomized multicenter study comparing conventional laparoscopic cholecystectomy versus minilaparotomy cholecystectomy with ultrasonic dissection as day surgery procedure - 1-year outcome. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 49 11: 1336-1342. 2014

Eskelinen Matti, Selander Tuomas, Lipponen Pertti, Juvonen Petri. 2014. History-Taking and the Usefulness Index in the Diagnosis of Functional Dyspepsia. Israel Medical Association Journal (IMAJ) 16 8: 497-501. 2014

Harju J, Aspinen S, Juvonen P, Kokki H, Eskelinen M. 2013. Ten-year outcome after minilaparotomy versus laparoscopic cholecystectomy: a prospective randomised trial. SURGICAL ENDOSCOPY January 2013: 1-5. 2013

Harju J, Juvonen P, Kokki H, Remes V, Scheinin T, Eskelinen M. 2013. Minilaparotomy cholecystectomy with ultrasonic dissection versus conventional laparoscopic cholecystectomy: a randomized multicenter study. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 48 11: 1317-1323. 2013

Regalado G, Lintula H, Eskelinen M, Kokki H, Kröger H, Svedström E, Vahlberg T, Väätäinen U. 2013. Dynamic KINE-MRI in patellofemoral instability in adolescents. KNEE SURGERY, SPORTS TRAUMATOLOGY, ARTHROSCOPY 2013: 1-8. 2013

Tuhkanen H, Hartikainen JM, Soini Y, Velasco G, Sironen R, Nykopp TK, Kataja V, Eskelinen M, Kosma VM, Mannermaa A.. 2013. Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer INTERNATIONAL JOURNAL OF CANCER 133 10: 2334-2340. 2013

Vaittinen M, Kaminska D, Käkelä P, Eskelinen M, Kolehmainen M, Pihlajamäki J, Uusitupa M, Pulkkinen L. 2013. Downregulation of CPPED1 expression improves glucose metabolism in vitro in adipocytes. DIABETES (NY) 62: 3747-3750. 2013

Kokki Merja, Broms Susanna, Eskelinen Matti, Rasanen Ilpo, Ojanperä Ilkka, Kokki Hannu. 2012. Analgesic concentrations of oxycodone--a prospective clinical PK/PD study in patients with laparoscopic cholecystectomy. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 110 5: 469-475. 2012

Soini, Y; Takasawa, A; Eskelinen, M; Juvonen, P; Kärjä, V; Hasegawa, T; Murata, M; Tanaka, S; Kojima, T; Sawada, N. 2012. Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation JOURNAL OF CLINICAL PATHOLOGY 65 5: 431-436. 2012

Lintula H, Kokki H, Juvonen P, Hämynen I, Heikkinen M, Eskelinen M. 2012. Severe gastro-oesophageal reflux necessitating fundoplication after percutaneous endoscopic and open gastrostomy in children. LANGENBECKS ARCHIVE OF SURGERY 2012 Published online: 31 January 2012: 5 pages. 2012

Eskelinen Matti, Lipponen Pertti. 2012. Usefulness index in nonspecific abdominal pain - an aid in the diagnosis?. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 47 12: 1475-1479. 2012

Kokki M, Välitalo P, Rasanen I, Aaltomaa S, Ojanperä I, Eskelinen M, Kokki H. 2012. Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 68: 1357-1363. 2012

Kokki M, Broms S, Eskelinen M, Neuvonen PJ, Halonen T, Kokki H. 2012. The Analgesic Concentration of Oxycodone with Co-administration of Paracetamol - A Dose-Finding Study in Adult Patients Undergoing Laparoscopic Cholecystectomy. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 111 6: 391-395. 2012

Eskelinen Matti, Lipponen Pertti. 2012. Usefulness of history-taking in non-specific abdominal pain: a prospective study of 1333 patients with acute abdominal pain in Finland. IN VIVO (ATHENS) 26 2: 335-339. 2012

Eskelinen, Matti; Ollonen, Paula. 2011. Measurement of pessimism: hopelessness scale in healthy study subjects, and in patients with benign breast disease and breast cancer: a prospective case-control study in Finland ANTICANCER RESEARCH 31 11: 4019-4023. 2011

Lintula, Hannu; Eskelinen, Matti; Kokki, Hannu. 2011. Reply to the Letter to the Editor. LANGENBECKS ARCHIVE OF SURGERY 396 6: 869. 2011

Eskelinen, Matti; Ollonen, Paula. 2011. Montgomery-Asberg Depression Rating Scale (MADRS) in healthy study subjects, in patients with breast disease and breast cancer: a prospective case-control study. ANTICANCER RESEARCH 31 3: 1065-1069. 2011

Purdy, Martin; Heikkinen, Markku; Juvonen, Petri; Voutilainen, Markku; Eskelinen, Matti. 2011. Characteristics of patients with a retained wireless capsule endoscope (WCE) necessitating laparotomy for removal of the capsule. IN VIVO (ATHENS) 25 4: 707-710. 2011

Eskelinen, Matti; Ollonen, Paula. 2011. Forsen psychological risk inventory for breast cancer patients: a prospective case-control study with special reference to the use of psychiatric medications. ANTICANCER RESEARCH 31 2: 739-744. 2011

Broeks, Annegien; Schmidt, Marjanka K; Sherman, Mark E; Couch, Fergus J; Hopper, John L; Dite, Gillian S; Apicella, Carmen; Smith, Letitia D; Hammet, Fleur; Southey, Melissa C; Van't Veer, Laura J; de Groot, Renate; Smit, Vincent T. H. B. M; Fasching, Peter A; Beckmann, Matthias W; Jud, Sebastian; Ekici, Arif B; Hartmann, Arndt; Hein, Alexander; Schulz-Wendtland, Ruediger et al.. 2011. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. HUMAN MOLECULAR GENETICS 20 16: 3289-3303. 2011

Eskelinen, Matti; Ollonen, Paula. 2011. Beck Depression Inventory (BDI) in patients with breast disease and breast cancer: a prospective case-control study. IN VIVO (ATHENS) 25 1: 111-116. 2011

Eskelinen, Matti; Ollonen, Paula. 2011. Sifneos alexithymia questionnaire in assessment of general alexithymia in patients with breast disease and breast cancer: a prospective case-control study in Finland. ANTICANCER RESEARCH 31 9: 3101-3106. 2011

Eskelinen, Matti; Ollonen, Paula. 2011. Assesment of general anxiety in patients with breast disease and breast cancer using the Spielberger STAI self evaluation test: a prospective case-control study in Finland ANTICANCER RESEARCH 31 5: 1801-1806. 2011

Eskelinen, Matti; Ollonen, Paula. 2011. Assessment of 'cancer-prone personality' characteristics in healthy study subjects and in patients with breast disease and breast cancer using the commitment questionnaire: a prostective case-control study in Finland ANTICANCER RESEARCH 31 11: 4013-4017. 2011

Eskelinen M & Ollonen P. 2010. The body image drawing analysis in women with breast disease and breast cancer: anxiety, colour and depression categories. ANTICANCER RESEARCH 30 2: 683-691. 2010

Eskelinen M, Ollonen P. 2010. Evaluation of women with breast disease using body image drawing analysis. ANTICANCER RESEARCH 30 6: 2399-2406. 2010

Eskelinen M, Ollonen P. 2010. Life stress and losses and deficit in adulthood as breast cancer risk factor: a prospective case-control study in Kuopio, Finland. IN VIVO (ATHENS) 24 6: 899-904. 2010

Eskelinen M, Ollonen P. 2010. Life stress due to losses and deficit in childhood and adolescence as breast cancer risk factor: a prospective case-control study in Kuopio, Finland. ANTICANCER RESEARCH 30 10: 4303-4308. 2010

Harju J, Kokki H, Pääkkönen M, Karjalainen K, Eskelinen M. 2010. Feasibility of minilaparotomy versus laparoscopic cholecystectomy for day surgery: a prospective randomised study. SCANDINAVIAN JOURNAL OF SURGERY 99 1: 132-136. 2010

Kauppinen J, Kosma V-M, Soini Y, Sironen R, Nissinen M, Nykopp T, Kärjä V, Eskelinen M, Kataja V, Mannermaa A. 2010. ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION 19 9: 2133-2142. 2010

Lintula H, Eskelinen M. 2010. Akuutin appendisiitin ongelmallinen diagnostiikka. DUODECIM 126 10: 1104-1106. 2010

Lintula Hannu, Kokki Hannu, Pulkkinen Jukka, Kettunen Riikka, Gröhn Oskari, Eskelinen Matti. 2010. Diagnostic score in acute appendicitis. Validation of a diagnostic score (Lintula score) for adults with suspected appendicitis. LANGENBECKS ARCHIVE OF SURGERY 395 5: 495-500. 2010

Eskelinen M, Ollonen P. 2009. Psychosocial risk scale (PRS) for breast cancer in patients with breast disease: a prospective case control study in Kuopio, Finland. ANTICANCER RESEARCH 29 11: 4765-4770. 2009

Lintula H, Kokki H, Kettunen R, Eskelinen M. 2009. Appendicitis score for children with suspected appendicitis. A randomized clinical trial. LANGENBECKS ARCHIVE OF SURGERY 394 6: 999-1004. 2009

Garcia-Closas M, Hall P, Nevanlinna H ..., Mannermaa A, Uusitupa M, Eskelinen M, Tengström M, Kosma V-M, Kataja V, Chenevix-Trench G .... 2008. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLOS GENETICS [ONLINE) 4 4: [e1000054]. 2008

Lintula H, Kokki H, Eskelinen M, Vanamo K. 2008. Laparoscopic versus open orchidopexy in children with intra-abdominal testes. JOURNAL OF LAPAROENDOSCOPIC AND ADVANCED SURGICAL TECHNIQUES. PART A 18 3: 449-456. 2008

Fagerholm Rainer, Hofstetter Barbara, Tommiska Johanna, Aaltonen Kirsimari, Vrtel Radek, Syrjäkoski Kirsi, Kallioniemi Anne, Kilpivaara Outi, Mannermaa Arto, Kosma Veli-Matti, Uusitupa Matti, Eskelinen Matti, Kataja Vesa, Aittomäki Kristiina. 2008. NAD(P)H:quinone oxidoreductase 1 NQ01*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. NATURE GENETICS 40 7: 844-853. 2008

Harju J, Pääkkönen M, Eskelinen M. 2007. Comparison of the quality of life after minilaparotomy cholecystectomy versus laparoscopic cholecystectomy: a prospective randomized study. ISRAEL MEDICAL ASSOCIATION JOURNAL - IMAJ 9: 147-148. 2007

Harju J, Pääkkönen M, Eskelinen M. 2007. Minilaparotomy cholecystectomy as a day surgery procedure: A prospective clinical pilot study SCANDINAVIAN JOURNAL OF SURGERY 96: 206-208. 2007

Järvinen M, Höckerstedt K, Alhava E, Juvonen T, Puolakkainen P, Aarnio P, Kivilaakso E, Eskelinen M, Lepäntalo M, Rintala R, Kröger H, Jalovaara P, Ruutu M, Kiviranta I, Tammela T, Tarkka M, Aro H, Serlo W, Mäkelä J, Harjula A. 2007. Kirurgian professorit: Selvityshenkilöiltä varsin radikaaleja ehdotuksia erikoislääkärikoulutuksesta. SUOMEN LÄÄKÄRILEHTI 62: 3777-3779. 2007

Mäkinen K, Loimas S, Hakala T, Eskelinen M. 2007. Tumour suppressor protein (p53), apoptosis inhibiting protein (Bcl-2) and proliferating cell nuclear antigen (PCNA) expressions in a rat pancreatic tumour model. ANTICANCER RESEARCH 27: 23-26. 2007

Ollonen P, Eskelinen M. 2007. Idealization as a risk factor for breast cancer in patients with breast disease - a prospective case-control study in Kuopio, Finland ANTICANCER RESEARCH 27: 1625-1630. 2007

Sillanpää P, Heikinheimo L, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H, Metsola K, Hirvonen A. 2007. CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish caucasian population. BREAST CANCER RESEARCH AND TREATMENT 104: 287-297. 2007

Harju J, Juvonen P, Eskelinen M, Miettinen P, Pääkkönen M. 2006. Minilaparotomy cholecystectomy versus laparoscopic cholecystectomy. SURGICAL ENDOSCOPY 20: 583-586. 2006

Hartikainen JM, Tuhkanen H, Kataja V, Eskelinen M, Uusitupa M, Kosma V-M, Mannermaa A. 2006. Refinement of the 22q12-q13 Breast Cancer-Associated Region:Evidence of TMPRSS6 as a Candidate in an Eastern Finnish Population CLINICAL CANCER RESEARCH 12 5: 1454-1462. 2006

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H, Mitrunen K. 2005. NAT2 slow acetylator genotype as an important modifier of breast cancer risk. INTERNATIONAL JOURNAL OF CANCER 114: 579-584. 2005

Ollonen P, Lehtonen J, Eskelinen M. 2005. Coping and defending as risk factors for breast cancer in patients with breast disease; a prospective case-control study in Kuopio, Finland ANTICANCER RESEARCH 25: 4623-4630. 2005

Sillanpää P, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A. 2005. Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. PHARMACOGENETICS AND GENOMICS 15: 749-752. 2005

Ollonen P, Lehtonen J, Eskelinen M. 2005. Stressful and adverse life experiences in patients with breast symptoms; a prospective case-control study in Kuopio, Finland. ANTICANCER RESEARCH 25: 531-536. 2005

Hartikainen JM, Tuhkanen H, Kataja V, Dunning AM, Antoniou A, Smith P, Arffman A, Pirskanen M, Easton DF, Eskelinen M, Uusitupa M, Kosma V-M, Mannermaa A. 2005. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in Eastern Finland: three candidate regions found. CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION 14 1: 75-80. 2005

Ollonen P, Lehtonen J, Eskelinen M. 2005. Anxiety, depression, and the history of psychiatric symptoms in patients with breast disease: a prospective case-control study in Kuopio, Finland. ANTICANCER RESEARCH 25: 2527-2534. 2005

Lintula H, Pesonen E, Kokki H, Vanamo K, Eskelinen M. 2005. A diagnostic score for children with suspected appendicitis LANGENBECKS ARCHIVE OF SURGERY 390: 164-170. 2005

Kokki H, Lintula H, Vanamo K, Heiskanen M, Eskelinen M. 2005. Oxycodone vs placebo in children with undifferentiated abdominal pain. A randomized, double-blind clinical trial of the effect of analgesia on diagnostic accuracy. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE 159: 320-325. 2005

Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, Kosma V-M, Uusitupa M, Hirvonen A. 2005. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in the Finnish case-control study. BREAST CANCER RESEARCH [ONLINE: HTTP://BREAST-CANCER-RESEARCH.COM/] 7: R987-R997. 2005

Eskelinen M, Nordén T, Lindgren A, Wide L, Adami HO, Holmberg L. 2004. Preoperative serum levels of follicle stimulating hormone (FSH) and prognosis in invasive breast cancer. EJSO - EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 30: 495-500. 2004

Lintula H, Kokki H, Vanamo K, Valtonen H, Mattila M, Eskelinen M. 2004. The costs and effects of laparoscopic appendectomy in children. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE 158: 34-37. 2004

Mustonen PK, Härmä MA, Eskelinen MJ. 2004. The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. SCANDINAVIAN JOURNAL OF SURGERY 93: 209-212. 2004

Pellikainen J, Naukkarinen A, Ropponen K, Rummukainen J, Kataja V, Kellokoski J, Eskelinen M, Kosma V-M. 2004. Expression of HER2 and its association with AP-2 in breast cancer EUROPEAN JOURNAL OF CANCER 40: 1485-1495. 2004

Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma V-M. 2004. Expression of matrix metalloproteinase (MMP)-2 and MMP-2 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. CLINICAL CANCER RESEARCH 10: 7621-7628. 2004

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H, Mitrunen K. 2004. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. PHARMACOGENETICS AND GENOMICS 14: 239-245. 2004

Romppanen J, Romppanen EL, Halonen T, Eskelinen M, Punnonen K. 2003. Reference values of serum total sialic acid for healthy adult subjects and comparison of two different calibrators for quantitation of total sialic acid in high performance anion-exchange chromatography with pulsed amperometric detection. CLINICAL CHEMISTRY AND LABORATORY MEDICINE 41 8: 1095-1096. 2003

Enholm S, Hienonen T, Suomalainen A, Lipton L, Tomlinson I, Kärjä V, Eskelinen M, Mecklin J-P, Karhu A, Järvinen HJ, Aaltonen LA. 2003. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. AMERICAN JOURNAL OF PATHOLOGY 163: 827-832. 2003

Pellikainen MJ, Pekola TT, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma V-M. 2003. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis JOURNAL OF CLINICAL PATHOLOGY 56: 214-220. 2003

Julkunen K, Mäkinen K, Kärjä V, Kosma V-M, Eskelinen M. 2003. Alpha-, beta- and chi-catenin expression in human pancreatic cancer. ANTICANCER RESEARCH 23: 5043-5048. 2003

Böhm J, Niskanen L, Tammi R, Tammi M, Eskelinen M, Pirinen R, Hollmen S, Alhava E, Kosma V-M. 2002. Hyaluronan expression in differentiated thyroid carcinoma. JOURNAL OF PATHOLOGY 196: 180-185. 2002

Eskelinen M, Haglund U. 2002. Serological tumor markers in pancreatic cancer. Teoksessa: Diamandis EP, Fritsche HA, Lilja H, Chan DW, Schwartz MK (toim.), Tumor Markers. Physiology, Pathobiology, Technology and Clinical Applications.American Association for Clinical Chemistry. ss. 265-268. 2002

Lintula H, Kokki H, Vanamo K, Antila P, Eskelinen M. 2002. Laparoscopy in children with complicated appendicitis JOURNAL OF PEDIATRIC SURGERY 37 9: 1317-1320. 2002

Mitrunen K, Kataja V, Eskelinen M, Kosma V-M, Kang D, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. 2002. Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. PHARMACOGENETICS AND GENOMICS 12: 67-72. 2002

Pellikainen J, Kataja V, Ropponen K, Kellokoski J, Pietiläinen T, Böhm J, Eskelinen M, Kosma V-M. 2002. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. CLINICAL CANCER RESEARCH 8: 3487-3495. 2002

Ropponen KM, Kellokoski JK, Pirinen RT, Moisio KI, Eskelinen MJ, Alhava EM, Kosma V-M. 2001. Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation. JOURNAL OF CLINICAL PATHOLOGY 54: 533-538. 2001

Setälä L, Lipponen P, Tammi R, Tammi M, Eskelinen M, Alhava E, Kosma V-M. 2001. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer. HISTOPATHOLOGY 38: 13-20. 2001

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, Kang D, Vainio H, Uusitupa M, Hirvonen A. 2001. Polymorphic catechol-O-methyltransferase gene and breast cancer risik. CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION 10: 635-640. 2001

Mitrunen K, Sillanpää P, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, Uusitupa M, Hirvonen A. 2001. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk CARCINOGENESIS 22 5: 827-829. 2001

Hirvonen A, Bouchardy C, Mitrunen K, Kataja V, Eskelinen M, Kosma V-M, Saarikoski ST, Jourenkova N, Anttila S, Dayer P, Uusitupa M, Benhamou S. 2001. Polymorphic GSTs and cancer predisposition. CHEMICO-BIOLOGICAL INTERACTIONS 133: 75-80. 2001

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. 2001. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION 10: 229-236. 2001

Karjalainen JM, Tammi RH, Tammi MI, Eskelinen MJ, Ågren UM, Parkkinen JJ, Alhava EM, Kosma V-M. 2000. Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. AMERICAN JOURNAL OF PATHOLOGY 157 3: 957-965. 2000

Salovaara R, Loukola A, Kristo P, Kääriäinen H, Ahtola H, Eskelinen M, Härkönen N, Julkunen R, Kangas E, Ojala S, Tulikoura J, Valkamo E, Järvinen H, Mecklin J-P, Aaltonen LA, de la Chapelle A. 2000. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY 18: 2193-2200. 2000

Ropponen KM, Kellokoski JK, Lipponen PK, Eskelinen MJ, Alanne L, Alhava EM, Kosma V-M. 2000. Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 35: 1204-1211. 2000

Mäkinen K, Loimas S, Nuutinen P, Eskelinen M, Alhava E. 2000. The growth pattern and microvasculature of pancreatic tumours induced with cultured carcinoma cells BRITISH JOURNAL OF CANCER 82 4: 900-904. 2000

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma V-M, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. 2000. Steroid metabolism gene CYP17 polymorpsm and the develpment of breast cancer. CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION 9: 1343-1348. 2000

Karjalainen JM, Kellokoski JK, Mannermaa AJ, Kujala HE, Moisio KI, Mitchell PJ, Eskelinen MJ, Alhava EM, Kosma VM. 2000. Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 alfa in cutaneous melanoma BRITISH JOURNAL OF CANCER 82 12: 2015-2021. 2000

Heikkinen M, Pikkarainen P, Eskelinen M, Julkunen R. 2000. GPs' ability to diagnose dyspepsia based only on physical examination and patient history. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE 18: 99-104. 2000

Böhm JP, Niskanen LK, Pirinen RT, Kiraly K, Kellokoski JK, Moisio KI, Eskelinen MJ, Tulla HE, Hollmen S, Alhava EM, Kosma V-M. 2000. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma JOURNAL OF PATHOLOGY 192: 321-327. 2000

Böhm J, Niskanen L, Kiraly K, Kellokoski J, Eskelinen M, Hollmen S, Alhava E, Kosma V-M. 2000. Expression and prognostic value of alfa-, beta- and gamma-catenins in differentiated thyroid carcinoma. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 85 12: 4806-4811. 2000

Auvinen P, Tammi R, Parkkinen J, Tammi M, Ågren U, Johansson R, Hirvikoski P, Eskelinen M, Kosma V-M. 2000. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. AMERICAN JOURNAL OF PATHOLOGY 156 2: 529-536. 2000

Setälä LP, Tammi MI, Tammi RH, Eskelinen MJ, Lipponen PK, Ågren UM, Parkkinen J, Alhava EM, Kosma V-M. 1999. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate BRITISH JOURNAL OF CANCER 79 7/8: 1133-1138. 1999

Karjalainen JM, Eskelinen MJ, Kellokoski JK, Reinikainen M, Alhava EM, Kosma V-M. 1999. p21 WAF1/CIP1 expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival. BRITISH JOURNAL OF CANCER 79 5/6: 895-902. 1999

Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava EM, Kosma V-M. 1999. Reduced expression of alfa catenin is associated with poor prognosis in colorectal carcinoma. JOURNAL OF CLINICAL PATHOLOGY 52 1: 10-16. 1999

Romppanen J, Keskikuru R, Kataja V, Eskelinen M, Kosma V-M, Savolainen K, Uusitupa M, Mononen I. 1999. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women BRITISH JOURNAL OF CANCER 79: 1583-1587. 1999

Loukola A, Salovaara R, Kristo P, Moisio A-L, Kääriäinen H, Ahtola H, Eskelinen M, Härkönen N, Julkunen R, Kangas E, Ojala S, Tulikoura J, Valkamo E, Järvinen H, Mecklin J-P, de la Chapelle A, Aaltonen LA. 1999. Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer. AMERICAN JOURNAL OF PATHOLOGY 155: 1849-1853. 1999

Keskikuru R, Kataja V, Kosma V-M, Eskelinen M, Uusitupa M, Johansson R, Risteli L, Risteli J, Jukkola A. 1999. Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer. ANTICANCER RESEARCH 19: 4481-4484. 1999

Ropponen KM, Kellokoski JK, Lipponen PK, Pietiläinen T, Eskelinen MJ, Alhava EM, Kosma V-M. 1999. p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. BRITISH JOURNAL OF CANCER 81 1: 133-140. 1999

Eskelinen MJ, Haglund UH. 1999. Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods. EUROPEAN JOURNAL OF SURGERY 165: 292-306. 1999

Eskelinen M, Haglund U. 1999. Developments in serologic detection of human pancreatic adenocarcinoma. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 34 9: 833-844. 1999

Böhm J, Kosma V-M, Eskelinen M, Hollmen S, Niskanen M, Tulla H, Alhava E, Niskanen L. 1999. Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma. EUROPEAN JOURNAL OF ENDOCRINOLOGY 141: 460-467. 1999

Aaltomaa S, Lipponen P, Eskelinen M, Ala-Opas M, Kosma VM. 1999. Prognostic value and expression of p21 (waf1/cip 1) protein in prostate cancer. PROSTATE 39: 8-15. 1999

Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K, Kosma V-M. 1999. Expression of cyclins A and D and p21 (waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. BRITISH JOURNAL OF CANCER 80 12: 2001-2007. 1999

Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Kosma V-M. 1999. Alfa-catenin expression has prognostic value in local and locally advanced prostate cancer BRITISH JOURNAL OF CANCER 80 3/4: 477-482. 1999

Aaltomaa S, Eskelinen M, Lipponen P. 1999. Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival. PROSTATE 38: 175-182. 1999

Eskelinen M, Kataja V, Hämäläinen E, Kosma V-M. 1999. Receiver-operating characteristics (ROC) curve analysis of cathepsin D and pS2 in breast disease; results from a prospective study. ANTICANCER RESEARCH 19: 3463-3468. 1999

Mäkinen K, Hakala T, Lipponen P, Alhava E, Eskelinen M. 1998. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma. ANTICANCER RESEARCH 18: 615-618. 1998

Setälä L, Kosma V-M, Lipponen P, Naukkarinen A, Nordling S, Hollmén S, Eskelinen M, Syrjänen K, Alhava E. 1998. Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 124 9: 497-502. 1998

Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma V-M. 1998. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 33: 301-309. 1998

Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, Ågren U, Alhava E, Kosma V-M. 1998. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. CANCER RESEARCH 58: 342-347. 1998

Pesonen E, Ohmann C, Eskelinen M, Juhola M. 1998. Diagnosis of acute appendicitis in two databases. Evaluation of different neighborhoods with a LVQ neural networks. METHODS OF INFORMATION IN MEDICINE 37: 59-63. 1998

Pesonen E, Eskelinen M, Juhola M. 1998. Treatment of missing data values in a neural network based decision support system for acute abdominal pain. ARTIFICIAL INTELLIGENCE IN MEDICINE 13: 139-146. 1998

Karjalainen JM, Kellokoski JK, Eskelinen MJ, Alhava EM, Kosma V-M. 1998. Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. JOURNAL OF CLINICAL ONCOLOGY 16 11: 3584-3591. 1998

Lipponen P, Aaltomaa S, Eskelinen M, Ala-Opas M, Kosma V-M. 1998. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value. EUROPEAN UROLOGY 34: 237-243. 1998

Lipponen P, Aaltoma S, Kosma V-M, Ala-Opas M, Eskelinen M. 1998. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up. JOURNAL OF PATHOLOGY 186: 157-164. 1998

Karjalainen JM, Eskelinen MJ, Nordling S, Lipponen PK, Alhava EM, Kosma V-M. 1998. Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma. BRITISH JOURNAL OF CANCER 77 11: 1917-1925. 1998

Eskelinen M, Ikonen J, Lipponen P. 1998. Usefulness of history-taking, physical examination and diagnostic scoring in acute renal colic. EUROPEAN UROLOGY 34: 467-473. 1998

Collan Y, Kumpusalo L, Pesonen E, Eskelinen M, Pajarinen P, Kettunen K. 1998. Prediction of survival in breast cancer: evaluation of different multivariate models. ANTICANCER RESEARCH 18: 647-650. 1998

Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomäki P, Chadwick RB, Kääriäinen H, Eskelinen M, Järvinen H, Mecklin J-P, de la Chapelle A, Julkunen R. 1998. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. NEW ENGLAND JOURNAL OF MEDICINE 338 21: 1481-1487. 1998

Vanninen E, Tenhunen-Eskelinen M, Eskelinen M, Tenhunen M, Alhava E. 1997. Uusi menetelmä syöpäkirurgiaan: kolorektaalisyövän levinneisyyden arviointi gammailmaisimella leikkauksen aikana. SUOMEN LÄÄKÄRILEHTI 52 6: 545-549. 1997

Setälä LP, Nordling S, Kosma V-M, Lipponen PK, Eskelinen MJ, Hollmén SM-L, Syrjänen KJ, Alhava EM. 1997. Comparison of DNA ploidy and s-phase fraction with prognostic factors in gastric cancer ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY 19 6: 524-532. 1997

Setälä L, Lipponen P, Kosma V-M, Marin S, Eskelinen M, Syrjänen K, Alhava E. 1997. Nuclear morphometry as a predictor of disease outcome in gastric cancer. JOURNAL OF PATHOLOGY 181: 46-50. 1997

Setälä L, Kosma V-M, Eskelinen M, Syrjänen K, Alhava E. 1997. Prognostic factors in gastric carcinoma. BRITISH JOURNAL OF CANCER 76 2: 279. 1997

Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma V-M,. 1997. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer JOURNAL OF PATHOLOGY 182: 318-324. 1997

Romppanen J, Eskelinen M, Tikanoja S, Mononen I. 1997. Total and lipid-bound serum sialic acid in benign and malignant breast disease. ANTICANCER RESEARCH 17: 1249-1254. 1997

Eskelinen M, Kataja V, Hämäläinen E, Kosma V-M, Penttilä I, Alhava E. 1997. Serum tumour markers CEA,AFP,CA 15-3,TPS and neu in diagnosis of breast cancer. ANTICANCER RESEARCH 17: 1231-1234. 1997

Auvinen PK, Parkkinen JJ, Johansson RT, Ågren UM, Tammi RH, Eskelinen MJ, Kosma V-M. 1997. Expression of hyaluronan in benign and malignant breast lesions INTERNATIONAL JOURNAL OF CANCER 74: 477-481. 1997

Aaltomaa S, Lipponen P, Vesalainen S, Ala-Opas M, Eskelinen M, Syrjänen K. 1997. Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer EUROPEAN UROLOGY 32: 410-415. 1997

Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K. 1997. Prognostic value of Ki-67 expression in renal cell carcinomas. EUROPEAN UROLOGY 31: 350-355. 1997

Heikkinen MT, Pikkarainen PH, Takala JK, Räsänen HT, Eskelinen MJ, Julkunen RJK. 1997. Diagnostic methods in dyspepsia: the usefulness of upper abdominal ultrasound and gastroscopy. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE 15: 82-86. 1997

Ropponen K, Eskelinen M, Kosma V-M, Lipponen P, Paakkinen P, Alhava E. 1996. Comparison of classic and quantitative prognostic factors in colorectal cancer ANTICANCER RESEARCH 16: 3875-3882. 1996

Zhu Z, Parviainen M, Männistö S, Pietinen P, Eskelinen M, Syrjänen K, Uusitupa M. 1996. Vitamin E concentration in breast adipose tissue of breast cancer patients (Kuopio, Finland). CANCER CAUSES AND CONTROL 7: 591-595. 1996

Setälä LP, Kosma V-M, Marin S, Lipponen PK, Eskelinen MJ, Syrjänen KJ, Alhava EM. 1996. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration BRITISH JOURNAL OF CANCER 74: 766-772. 1996

Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma V-M, Syrjänen K. 1996. The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 122: 687-692. 1996

Pesonen E, Eskelinen M, Juhola M. 1996. Comparison of different neural network algorithms in the diagnosis of acute appendicitis. INTERNATIONAL JOURNAL OF BIO-MEDICAL COMPUTING 40: 227-233. 1996

Männistö S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M. 1996. Body-size indicators and risk of breast cancer according to menopause and estrogen-reseptor status. INTERNATIONAL JOURNAL OF CANCER 68: 8-13. 1996

Lipponen PK, Aaltomaa S, Eskelinen M. 1996. Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours. HISTOPATHOLOGY 28: 135-140. 1996

Hakkarainen M, Wahlfors J, Myöhänen S, Hiltunen MO, Eskelinen M, Johansson R, Jänne J. 1996. Hypermethylation of calcitonin gene regulatory sequences in human breast cancer as revealed by genomic sequencing INTERNATIONAL JOURNAL OF CANCER 69: 471-474. 1996

Pasanen P, Eskelinen M, Kulju A, Penttilä I, Janatuinen E, Alhava E. 1995. Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242. SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION 55: 119-124. 1995

Zhu ZR, Parviainen M, Männistö S, Pietinen P, Eskelinen M, Syrjänen K, Uusitupa M. 1995. Vitamin A concentration in breast adipose tissue of breast cancer patients. ANTICANCER RESEARCH 15: 1593-1596. 1995

Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma V-M, Syrjänen K. 1995. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. EUROPEAN JOURNAL OF CANCER 31A 3: 329-333. 1995

Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma V-M, Syrjänen K. 1995. Expression of p53 protein has no independent prognostic value in breast cancer. JOURNAL OF PATHOLOGY 177: 225-232. 1995

Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma V-M, Syrjänen K. 1995. Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. ANTICANCER RESEARCH 15: 959-964. 1995

Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E. 1995. Multivariate analysis of six serum tumor markers (CEA, CA50, CA242,TPA, TPS, TATI) and conventional Laboratory tests in the diagnosis of hepatopancreatobiliary malignancy. ANTICANCER RESEARCH 15: 2731-2738. 1995

Eskelinen M, Ikonen J, Lipponen P. 1995. The value of history-taking, physical examination, and computer assistance in the diagnosis of acute appendicitis in patients more than 50 years old. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 30: 349-355. 1995

Mäkinen K, Eskelinen M, Lipponen P, Alhava E. 1995. Expression of C-242 antigen in pancreatic ductal adenocarcinoma. ANTICANCER RESEARCH 15: 1605-1608. 1995

Lipponen PK, Eskelinen MJ. 1995. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 121: 303-308. 1995

Lipponen P, Pietiläinen T, Kosma V-M, Aaltomaa S, Eskelinen M, Syrjänen K. 1995. Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis JOURNAL OF PATHOLOGY 177: 49-55. 1995

Lipponen P, Eskelinen M, Syrjänen K. 1995. Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. BRITISH JOURNAL OF CANCER 71: 863-867. 1995

Eskelinen M, Pasanen P, Janatuinen E, Pettersson N, Linnane A, Alhava E. 1995. Small intestinal mucin antigen (SIMA); A novel tumour marker in colorectal cancer?. ANTICANCER RESEARCH 15: 2351-2356. 1995

Eskelinen M, Lipponen P, Nordling S. 1995. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma ANTICANCER RESEARCH 15: 2279-2284. 1995

Zhu ZR, Ågren J, Männistö S, Pietinen P, Eskelinen M, Syrjänen K, Uusitupa M. 1995. Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with bening breast disease. NUTRITION AND CANCER 24: 151-160. 1995

Yhteystiedot

Organisaatio

Sähköposti

Puhelin

Tutkimusryhmät - UEF

Julkaisut